Philadelphia is joining the San Francisco Bay area, Boston, and San Diego as a host of a Lilly Gateway Labs biotech incubator ...

Pharmaceutical giant Eli Lilly and Co. is bringing its next Gateway Labs to Philadelphia. Here's where and why.

Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing ...

Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, developed 2300 Market to be the most comprehensive R&D ecosystem in the Philadelphia market. Legend Biotech selected the ...

As the biopharma world predominantly invests in late-stage assets, Eli Lilly is prioritizing early science with the opening ...

Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.

To provide access to dedicated, fully equipped wet lab facilities and strategic scientific engagement.

Eli Lilly & Co. is bringing a pharmaceutical startup incubator to 2300 Market St. MCB Science + Health has finished the ...

Eli Lilly (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 square feet of ...

Bayada is bringing in a chief executive from outside the founding family for the first time in the company's 50-year history.

This expansion supports a strategic initiative to embed Eli Lilly within emerging biotechnology ecosystems. The Gateway Labs program provides promising startups with modern laboratory space and direct ...

La Mancha Investments S. à r. l. (La Mancha), a wholly owned subsidiary of La Mancha Resource Fund SCSp (which is advised by La Mancha Resource Capital LLP), announces today that between ...